Although Rho GTPases have been shown to be required for cellular functions associated with tumour progression and invasiveness (Schmitz et al, 2000; Price and Collard, 2001), studies supporting the role of Rho for carcinogenesis and tumour progression in patients with cancer are largely missing. This evidence concerns the gene RHO and neoplasm.